Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis

David R. Boulware,David B. Meya,Conrad Muzoora,Melissa A. Rolfes,Katherine Huppler Hullsiek,Abdu K Musubire,Kabanda Taseera,Henry W. Nabeta,Charlotte Schutz,Darlisha A. Williams,Radha Rajasingham,Joshua Rhein,Friedrich Thienemann,Melanie W. Lo,Kirsten Nielsen,Tracy L. Bergemann,Andrew Kambugu,Yukari C. Manabe,Edward N. Janoff,Paul R. Bohjanen,Graeme Meintjes

Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis

2014

Supported by grants from the National Institute of Allergy and Infectious Diseases (NIAID; U01AI089244, K23AI073192, T32AI055433, and K24AI096925), the Wellcome Trust (081667 and 098316 and the Veterans Affairs Research Service

Keywords:

Cause of death
AIDS-Related Opportunistic Infections
Amphotericin B
Allergy
Surgery
Cerebrospinal Fluid Otorrhea
Meningitis
Survival analysis
Veterans Affairs
Medicine
antiretroviral therapy
cryptococcal meningitis

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

296

Citations